These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35084650)

  • 1. Kidney failure, CKD progression and mortality after nephrectomy.
    Ellis RJ; Cameron A; Gobe GC; Diwan V; Healy HG; Lee J; Tan KS; Venuthurupalli S; Zhang J; Hoy WE;
    Int Urol Nephrol; 2022 Sep; 54(9):2239-2245. PubMed ID: 35084650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.
    Provenzano M; Chiodini P; Minutolo R; Zoccali C; Bellizzi V; Conte G; Locatelli F; Tripepi G; Del Vecchio L; Mallamaci F; Di Micco L; Russo D; Heerspink HJL; De Nicola L
    Nephrol Dial Transplant; 2020 Jan; 35(1):138-147. PubMed ID: 30053127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial.
    Wheeler DC; Stefánsson BV; Jongs N; Chertow GM; Greene T; Hou FF; McMurray JJV; Correa-Rotter R; Rossing P; Toto RD; Sjöström CD; Langkilde AM; Heerspink HJL;
    Lancet Diabetes Endocrinol; 2021 Jan; 9(1):22-31. PubMed ID: 33338413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study.
    Chinnadurai R; Clarke NW; Kalra PA
    BMC Nephrol; 2020 May; 21(1):202. PubMed ID: 32471368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP).
    Haynes R; Staplin N; Emberson J; Herrington WG; Tomson C; Agodoa L; Tesar V; Levin A; Lewis D; Reith C; Baigent C; Landray MJ;
    Am J Kidney Dis; 2014 Jul; 64(1):40-8. PubMed ID: 24613056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incident Chronic Kidney Disease After Radical Nephrectomy for Renal Cell Carcinoma.
    Ellis RJ; White VM; Bolton DM; Coory MD; Davis ID; Francis RS; Giles GG; Gobe GC; Marco DJT; Neale RE; Wood ST; Jordan SJ;
    Clin Genitourin Cancer; 2019 Jun; 17(3):e581-e591. PubMed ID: 30975606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On-clamp versus purely off-clamp robot-assisted partial nephrectomy in solitary kidneys: comparison of perioperative outcomes and chronic kidney disease progression at two high-volume centers.
    Anceschi U; Brassetti A; Bertolo R; Tuderti G; Ferriero MC; Mastroianni R; Flammia RS; Costantini M; Kaouk J; Leonardo C; Gallucci M; Simone G
    Minerva Urol Nephrol; 2021 Dec; 73(6):739-745. PubMed ID: 32573170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
    Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
    Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of outcomes of chronic kidney disease based on etiology: a prospective cohort study from KNOW-CKD.
    Ryu H; Hong Y; Kang E; Kang M; Kim J; Park HC; Oh YK; Chin HJ; Park SK; Jung JY; Hyun YY; Sung SA; Ahn C; Oh KH;
    Sci Rep; 2023 Mar; 13(1):3570. PubMed ID: 36864195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of new-onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: An Australian population-based analysis.
    Ahn T; Ellis RJ; White VM; Bolton DM; Coory MD; Davis ID; Francis RS; Giles GG; Gobe GC; Hawley CM; Johnson DW; Marco DJT; McStea M; Neale RE; Pascoe EM; Wood ST; Jordan SJ;
    J Surg Oncol; 2018 Jun; 117(7):1597-1610. PubMed ID: 29790163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM
    Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study.
    Chinnadurai R; Flanagan E; Jayson GC; Kalra PA
    BMC Nephrol; 2019 Oct; 20(1):380. PubMed ID: 31640599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum uric acid variability increases the risk of postoperative chronic kidney disease in patients with renal cell carcinoma after radical nephrectomy.
    Li X; Li Z; Wu X; Zhang M; Xu L; Hao X; Li H; Qiao P; Wang W
    Urol Oncol; 2021 Aug; 39(8):500.e1-500.e7. PubMed ID: 34187751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD.
    Srivastava A; Kaze AD; McMullan CJ; Isakova T; Waikar SS
    Am J Kidney Dis; 2018 Mar; 71(3):362-370. PubMed ID: 29132945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
    Chen PM; Wada T; Chiang CK
    Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Yang W; Xie D; Anderson AH; Joffe MM; Greene T; Teal V; Hsu CY; Fink JC; He J; Lash JP; Ojo A; Rahman M; Nessel L; Kusek JW; Feldman HI;
    Am J Kidney Dis; 2014 Feb; 63(2):236-43. PubMed ID: 24182662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent or synergistic relationship of proteinuria and glomerular filtration rate on patient and renal survival in patients with glomerulonephritis?
    Haider DG; Masghati S; Goliasch G; Fuhrmann V; Soleiman A; Wolzt M; Baierl A; Druml W; Hörl WH
    J Nephrol; 2014 Dec; 27(6):643-51. PubMed ID: 24609889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.